comparemela.com

Latest Breaking News On - Brian pall - Page 1 : comparemela.com

5 top ophthalmic device innovations you need to know

Innovation finds its way into all areas of medtech, and ophthalmic treatments represent another burgeoning space.

Clareon monofocalAcuvue oasys maxAcuvue theravisionPrix galien internationalSight sciencesSight sciences nasdaqJohnson visionClinica scienceBrian pallClareon toricGalien international awardsStent infiniteClearside biomedical

The First Drug-Releasing Contact Lens Is Here

The FDA has approved daily disposables that release anti-allergy medication. Experts hope lenses could one day help treat cataracts and glaucoma.

Melissa barnettDrug administrationUc davis eye centerEye centerBrian pallPharmaceutical industry

Johnson & Johnson is bringing the world s first drug-eluting contact lens to market

Johnson & Johnson has a potential alternative to eye drops with its drug-eluting Acuvue Theravision contact lens.

Acuvue theravisionJohnson visionClinica scienceBrian pallDrug delivery business newsthat

New Contact Lens Elutes Antihistamine for Ocular Allergy

A new contact lens that elutes antihistamine has been approved by the US Food and Drug Administration as a treatment for ocular allergies.

Drug administrationBrian pallJohnson vision careAcuvue theravision with ketotifenisRefractive errorContact lensesAllergic conjunctivitisOcular allergiesLlergic eye diseasesLlergic ophthalmologic conditionsVision care and maintenanceClinical researchClinical trialsLinical studiesCorneal diseaseHealthcare and medical technology

J&J receives FDA approval for drug-eluting contact lens

The FDA approved Johnson and Johnson Vision Care's Acuvue Theravision with the antihistamine Ketotifen to treat allergy-induced itchy eyes for contact lens wearers.

United statesAcuvue theravisionJohnson medical device companiesJohnson vision careBrian pallJohnson visionWeight lossMedical devicesHealthcare innovationMedcity newsMedcity newsSan franciscoLife sciencesRock healthStartup adviceStartup funding

vimarsana © 2020. All Rights Reserved.